BioMarin Pharmaceutical Inc. (LON: 0HNC)
London
· Delayed Price · Currency is GBP · Price in USD 61.70
-0.42 (-0.68%)
Jan 23, 2025, 2:45 PM BST
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of 9.60 billion as of January 23, 2025. Its market cap has decreased by -32.73% in one year.
Market Cap
9.60B
Enterprise Value
9.33B
Revenue
2.05B
Ranking
n/a
PE Ratio
39.91
Stock Price
61.70
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 283.77M to 9.60B, an increase of 3,282.07%. That is a compound annual growth rate of 14.79%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.81B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 1.99B |
| Oxford Nanopore Technologies | 1.42B |